Science Explorer Interactive view Map
Company · New York · United States

Actinium Pharmaceuticals (United States)

actiniumpharma.comROR OpenAlex
Research works
49
▲ 386% vs 2013–17
Citations
237
4.9 per fractional work
Top-10% rate
4.6%
record average 16.5%
Open access
25%
world 28%

Not ranked overall: Actinium Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.14× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 7.19× its world share, 1 worksImmunology and Micro…Chemistry: 1.82× its world share, 0 worksChemistryComputer Science: 0.15× its world share, 0 worksComputer ScienceEngineering: 0.09× its world share, 0 worksEngineeringMaterials Science: 0.99× its world share, 1 worksMaterials ScienceMathematics: 1.00× its world share, 0 worksMathematicsPhysics and Astronomy: 0.51× its world share, 0 worksPhysics and AstronomyMedicine: 3.93× its world share, 14 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.2×. Every wedge is a field page.

Who are the top researchers at Actinium Pharmaceuticals (United States)?

Ranked on the composite score, Mark S. Berger, Dale L. Ludwig and Debbie Lewis lead among researchers whose main affiliation is Actinium Pharmaceuticals (United States).

  1. 1 Mark S. Berger United States · #88,713 worldwide 331 citations · 26 works
  2. 2 Dale L. Ludwig United States · #1,267,921 worldwide 39 citations · 29 works
  3. 3 Debbie Lewis United States · #1,393,174 worldwide 5 citations · 18 works
All ranked researchers at Actinium Pharmaceuticals (United States)

Which keywords describe research at Actinium Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, PET Imaging, Dosimetry, Cancer Treatment, Radioimmunotherapy, Radiopharmaceuticals, Immunotherapy and Prognostic Factors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Targeted Therapy10▲ 91×4 topics
  2. PET Imaging8▲ 81×3 topics
  3. Dosimetry8▲ 187×2 topics
  4. Cancer Treatment8▲ 64×2 topics
  5. Radioimmunotherapy8▲ 415×1 topic
  6. Radiopharmaceuticals8▲ 415×1 topic
  7. Immunotherapy6▲ 20×6 topics
  8. Prognostic Factors6▲ 27×4 topics
  9. Monoclonal Antibodies5▲ 68×2 topics
  10. Cancer Immunotherapy4▲ 66×3 topics
  11. Glycosylation4▲ 41×2 topics
  12. Hematopoietic Stem Cells4▲ 88×3 topics
  13. Fc Receptors4▲ 88×1 topic
  14. Therapeutic Antibodies4▲ 68×1 topic
  15. AML4▲ 183×1 topic
  16. Acute Myeloid Leukemia4▲ 183×1 topic
  17. Chemotherapy4▲ 11×5 topics
  18. Tumor Regression3▲ 75×2 topics
  19. Lymphoma3▲ 43×2 topics
  20. CAR T Cells3▲ 142×1 topic
  21. Chimeric Antigen Receptor3▲ 142×1 topic
  22. Biomedical Applications3▲ 5.0×4 topics
  23. Staging System3▲ 85×2 topics
  24. ALK2▲ 123×1 topic
  25. Genetic Mutations2▲ 8.0×2 topics
  26. Nanoparticles2▲ 3.1×3 topics
  27. Neuroblastoma2▲ 123×1 topic
  28. Breast Cancer2▲ 14×2 topics
  29. Cancer Therapy2▲ 6.0×3 topics
  30. HER22▲ 120×1 topic
  31. Trastuzumab2▲ 85×1 topic
  32. Medicinal Chemistry2▲ 8.7×3 topics
  33. Clinical Trials2▲ 5.0×2 topics
  34. Tumor Targeting2▲ 23×3 topics
  35. Drug Discovery1▲ 7.1×3 topics
  36. Imaging1▲ 7.9×2 topics
  37. Carbon Nanotubes1▲ 7.8×2 topics
  38. Immunity1▲ 7.9×2 topics
  39. Minimal Residual Disease1▲ 38×2 topics
  40. Supramolecular Chemistry1▲ 22×3 topics

Which research topics does Actinium Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Radiopharmaceutical Chemistry and Applications, Acute Myeloid Leukemia Research, Monoclonal and Polyclonal Antibodies Research and CAR-T cell therapy research.

Radiopharmaceutical Chem…3Radiopharmaceutical Chemistry and Applications: 3 fractional worksAcute Myeloid Leukemia R…3Acute Myeloid Leukemia Research: 3 fractional worksMonoclonal and Polyclonal Antibodies Research: 2 fractional worksCAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksHER2/EGFR in Cancer Rese…1HER2/EGFR in Cancer Research: 1 fractional worksLung Cancer Research Studies: 1 fractional worksNanoparticle-Based Drug Delivery: 0 fractional worksNeuroblastoma Research and Treatments: 0 fractional worksImmune cells in cancer: 0 fractional worksLung Cancer Treatments and Mutations: 0 fractional works
Radiology, Nuclear Medicine and ImagingHematologyOncologyBiomaterials3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 3 works
  2. 2 Acute Myeloid Leukemia Research Hematology 3 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  4. 4 CAR-T cell therapy research Oncology 2 works
  5. 5 HER2/EGFR in Cancer Research Oncology 1 works
  6. 6 Lung Cancer Research Studies Oncology 1 works
  7. 7 Nanoparticle-Based Drug Delivery Biomaterials 0 works
  8. 8 Neuroblastoma Research and Treatments Neurology 0 works
  9. 9 Immune cells in cancer Immunology 0 works
  10. 10 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available25.1%not open74.9%

World: 28% of research is openly available.

with international co-authors34.1%domestic only65.9%

World: 19% is written across borders.

How has Actinium Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 386% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in New York

All research institutions in New York

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.